Post-market Observation of a Wireless Vital Sign Monitor for Hospitalized

Status Recruiting

Clinical Trial Summary

The goal of this study is to measure the clinical impact and cost-effectiveness of a wireless vital signs monitor, neoGuard, for hospitalized newborns at a tertiary healthcare facility in Kenya. The main questions it aims to answer are: 1. Does the neoGuard vital signs monitor detect meaningful vital sign changes in hospitalized newborns? 2. Does the neoGuard vital signs monitor generate valid signals to trigger a timely response from nurses? 3. Is the neoGuard vital signs monitor associated with improved patient outcomes and lower mortality? 4. What is the cost-effectiveness of the neoGuard vital signs monitor in comparison to the standard-of-care monitoring system? Participants will be enrolled within the first 24 hours of admission and monitored for a period of 7 consecutive days or until they are discharged (whichever comes sooner). The study will consist of an intervention group and a comparison group. Researchers will compare nurses' response time to patients in distress, newborn complication rates and treatment outcomes between the two groups.

Clinical Trial Description

This is an interrupted time series study conducted at the Moi Teaching and Referral Hospital (MTRH) neonatal ward between April 2022 and June 2023. Our study participants comprise of newborn patients admitted at MTRH during that period. The MTRH neonatal ward is arranged in 8 sub-units which comprise our comparison sub-groups. Newborns admitted from April-November 2022 comprise the pre-intervention arm and are not exposed to neoGuard, but receive existing standard-of-care vital sign monitoring. In December 2022, neoGuard was installed in 4 sub-units (intervention group), while the remaining 4 sub-units (comparison group) continued to use standard-of-care monitoring. The measurement of effectiveness will be performed at three levels: (1) device's ability to detect abnormal physiological signals and provide alerts/alarms that notify the nurses to check on a patient's status and; (2) alarms/alerts from level one that resulted in a necessary intervention being administered to the patient (valid alarms), versus all the alarms/alerts that did not necessitate an intervention (invalid alarms); (3) the month-to-month difference in newborn complication rates and treatment outcomes between the intervention group and comparison group. Medical staff who interact with neoGuard will participate in user surveys at the end of the intervention period to capture user experience and perceptions on feasibility and sustainability. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05728307
Study type	Observational
Source	Neopenda, PBC
Contact	Assumpta S Nantume, MSc
Phone	2037472391
Email	assumpta@neopenda.com
Status	Recruiting
Phase
Start date	November 28, 2022
Completion date	November 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04070066` - Educational Strategy IN Exchange Transfusion	N/A
Recruiting	`NCT04405700` - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Completed	`NCT04258722` - Reducing Adverse Delivery Outcomes Through Teleneonatology: A Feasibility Study	N/A
Completed	`NCT01346813` - Epidemiology of Painful Procedures in Neonates	N/A
Active, not recruiting	`NCT04054453` - Prevention of Epilepsy by Reducing Neonatal Encephalopathy	N/A
Active, not recruiting	`NCT04184544` - Scaling up Evidence Based MNCH Interventions : A Quasi Experimental Study Umeed e Nau (UeN) Project	N/A
Recruiting	`NCT06256406` - Effects of Confortable Environment, Kangaroo Care and Music Therapy in Newborns in Neonatal Intensive Care Unit	N/A
Completed	`NCT04925908` - Exclusive Breastfeeding in Infants of Mothers Infected With Novel Coronavirus
Recruiting	`NCT03235635` - Metagenomic Analysis of Gut Microbiome in Preterm	N/A
Completed	`NCT04323397` - Nasal HFOV Versus Nasal SIPPV in Neonate Following Extubation: RCT Crossover Study	N/A
Completed	`NCT04422041` - Comparison of Early Versus Very Early Postnatal Discharge on Hospital Readmissions in Newborns	N/A
Completed	`NCT02643472` - GPS (Giving Parents Support): Parent Navigation After NICU Discharge	N/A
Recruiting	`NCT06081075` - Newborn Genomics Programme
Recruiting	`NCT05639309` - Liver Regional Oxygen Saturation in Preterm Patent Ductus Arteriosus
Completed	`NCT03350022` - Sham Feeding Post-operative Infants	N/A
Recruiting	`NCT06170892` - Kangaroo Position in Preterm Newborn Infants Under Oxygen Therapy	N/A
Completed	`NCT06130488` - Implementation at Scale and Evaluation of KMC	N/A
Not yet recruiting	`NCT03786497` - Protecting Brains and Saving Futures - the PBSF Protocol
Completed	`NCT04191239` - Comparing Two Different Modes of Ventilation in Pretem Neonates Bilevel VG and PRVC
Completed	`NCT04734002` - Neonatal Surgery Intensive Care Unit: Hacettepe Experience

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Post-market Observation of a Wireless Vital Sign Monitor for Hospitalized Newborns in Kenya

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms